Cargando…
Fragment-Based Screening by Protein Crystallography: Successes and Pitfalls
Fragment-based drug discovery (FBDD) concerns the screening of low-molecular weight compounds against macromolecular targets of clinical relevance. These compounds act as starting points for the development of drugs. FBDD has evolved and grown in popularity over the past 15 years. In this paper, the...
Autores principales: | Chilingaryan, Zorik, Yin, Zhou, Oakley, Aaron J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Molecular Diversity Preservation International (MDPI)
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3497300/ https://www.ncbi.nlm.nih.gov/pubmed/23202926 http://dx.doi.org/10.3390/ijms131012857 |
Ejemplares similares
-
Fragment-Based Discovery of Inhibitors of the Bacterial DnaG-SSB Interaction
por: Chilingaryan, Zorik, et al.
Publicado: (2018) -
Novel Starting Points for Human Glycolate Oxidase Inhibitors, Revealed by Crystallography-Based Fragment Screening
por: Mackinnon, Sabrina R., et al.
Publicado: (2022) -
An expanded allosteric network in PTP1B by multitemperature crystallography, fragment screening, and covalent tethering
por: Keedy, Daniel A, et al.
Publicado: (2018) -
Protein Crystallography in Vaccine Research and Development
por: Malito, Enrico, et al.
Publicado: (2015) -
Why is interoperability between the two fields of chemical crystallography and protein crystallography so difficult?
por: Brink, Alice, et al.
Publicado: (2019)